Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
r-TPA vs standard therapy in wake-up ischemic stroke within 3 hours
2010-019359-23Phase 2Terminated
- Sponsor
- Fondazione Centro San Raffaele
- Start
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tissue-plasminogen activator in ischemic stroke (2 arms), sponsored by Fondazione Centro San Raffaele. Primary endpoint: Functional independence at 3 months. Started Mar 2010; status: terminated.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2010-019359-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019359-23.